India To Start Clinical Trials Of U.S Based 2nd Gen Vaccines

As per reports, India has planned to start clinical trials of the US- based Akston Biosciences' second generation COVID-19 vaccine. Reportedly, the vaccine can be produced at a much lower cost, that requires no refrigeration and has a shelf life of six months. Moreover, samples of the vaccine has been sent to a government laboratory to check for safety prior to starting clinical trials in India, as per reports .